QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, patients received the agent via subcutaneous injection every three weeks ...
Magnesite plays a vital role in India's industry and energy security why experts urge its inclusion in critical mineral ...
A North East research centre has developed a process that allows researchers and industrial partners to examine how materials ...
Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.
The Calcutta High Court has set aside a Patent Office order rejecting a patent application filed by OCV Intellectual Capital ...
IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...
Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...
NeuroScientific Biopharmaceuticals’ stem cell tech has delivered real-world promise for those with Crohn’s disease, ...
The incinerators operate at temperatures of up to 1,200 degrees Celsius, using a dual-chamber system. “The primary chamber ...
Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) is included on our list of stocks under $1 that will explode. On December 18, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback